RTKs such as epidermal growth factor receptor (EGF-R), platelet-derived growth factor receptor (PDGF-R) and insulin-like growth factor 1 receptor (IGF1-R) involved in proliferation, survival and invasiveness of GBM are frequently altered and over-activated [14]. The gene discussed is EGFR; the disease is glioblastoma.